425256004: Product containing ranibizumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Product containing protein and/or protein derivative (product)\Product containing protein (product)\Product containing antibody (product)\Product containing monoclonal antibody (product)\Product containing ranibizumab (medicinal product)

\Medicinal product categorized by disposition (product)\Product containing angiogenesis inhibitor (product)\Product containing ranibizumab (medicinal product)

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Product containing protein (product)\Product containing antibody (product)\Product containing monoclonal antibody (product)\Product containing ranibizumab (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3523203019 Product containing ranibizumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3716427010 Ranibizumab-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3502271000005115 ranibizumab da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing ranibizumab (medicinal product)	Is a	Product containing angiogenesis inhibitor (product)	true	Inferred relationship	Some
Product containing ranibizumab (medicinal product)	Is a	Product containing monoclonal antibody (product)	true	Inferred relationship	Some
Product containing ranibizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ranibizumab (substance)	true	Inferred relationship	Some	1
Product containing ranibizumab (medicinal product)	Is a	lægemidler til anvendelse i øjnene	false	Inferred relationship	Some
Product containing ranibizumab (medicinal product)	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Some
Product containing ranibizumab (medicinal product)	Is a	Product manufactured as ocular dose form (product)	false	Inferred relationship	Some
Product containing ranibizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Angiogenesis inhibitor	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	Is a	False	Product containing ranibizumab (medicinal product)	Inferred relationship	Some
Ranibizumab only product	Is a	True	Product containing ranibizumab (medicinal product)	Inferred relationship	Some
Ranibizumab-containing product in parenteral dose form	Is a	True	Product containing ranibizumab (medicinal product)	Inferred relationship	Some

This concept is not in any reference sets